- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06220851
Correlation Between Handgrip Strength and Air Trapping in Patients with Stable Chronic Obstructive Pulmonary Disease
January 16, 2025 updated by: Narongkorn Saiphoklang, MD, Thammasat University
The goal of this observational study is to investigate the relationship between handgrip strength and air trapping in patients with chronic obstructive pulmonary disease (COPD). The main question it aims to answer is:
• Is handgrip strength correlated with air trapping in COPD patients? Participants will perform handgrip strength test and lung volume measurement.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a cross-sectional study in COPD patients.
COPD patients aged 40 years or older were included.
Handgrip strength test and lung volume measurement will be tested in each patient.
Handgrip strength will be measured using a hand dynamometer.
Lung volume will be assessed using a body plethysmograph.
Study Type
Observational
Enrollment (Actual)
72
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pathumthani, Thailand, 12120
- Thammasat University Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
COPD patients aged 40 years or older who are confirmed diagnosis by spirometry (postbronchodilator FEV1/FVC <0.7) and smoking history 10 pack-years or more.
Description
Inclusion Criteria:
- Age 40 years or older
- Postbronchodilator FEV1/FVC <0.7
- >10 pack-year smoking history
Exclusion Criteria:
- COPD exacerbation within 3 months
- Inability to perform handgrip strength test or lung volume measurement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
COPD
COPD patients aged 40 years or older with a postbronchodilator ratio of forced expiratory volume at one second (FEV1) to forced vital capacity (FVC) <0.7.
|
Handgrip strength will be measured by 3 efforts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Correlation between handgrip strength and air trapping in COPD patients
Time Frame: At day 1 of the study
|
This correlation will be reported as correlation coefficient (R).
|
At day 1 of the study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The best cutoff value of handgrip strength for predicting air trapping in COPD patients
Time Frame: At day 1 of the study
|
The best cutoff value will be determined by the area under the Receiver Operator Characteristic curve (ROC).
|
At day 1 of the study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Actual)
December 31, 2023
Study Completion (Actual)
May 31, 2024
Study Registration Dates
First Submitted
January 12, 2024
First Submitted That Met QC Criteria
January 23, 2024
First Posted (Actual)
January 24, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 16, 2025
Last Verified
January 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MTU-EC-IM-0-209/65
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual patient data (IPD) and documents will be available for sharing immediately after publication for a period of 2 years.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance
Clinical Trials on Handgrip strength
-
University of LiegeUnknownQuality of Life | Critical Illness | Muscle Strength | Grip Strength | Quadriceps StrengthBelgium
-
Centre Hospitalier Régional d'OrléansCompletedEffect of Vibratory Tendon Stimulation on Muscle Fatigue in the Acute Post-stroke Phase (VIBRAMAIN1)Stroke | Fatigue | Stroke, AcuteFrance
-
University of SouthamptonUniversity Hospital Southampton NHS Foundation TrustUnknownInflammatory Bowel Disease | Nutrition
-
Shanxi Provincial People's HospitalThe First Affiliated Hospital of Henan University of Science and TechnologyCompletedHandgrip Strength | Transjugular Intrahepatic Portosystemic Shunts (TIPS)China
-
Riphah International UniversityCompletedSports Physical TherapyPakistan
-
CHU de ReimsCompletedChemotherapy | Sarcopenia | Muscle Strength | Digestive Cancer | Handgrip Strength Test
-
Gazi UniversityActive, not recruitingPulmonary HypertensionTurkey
-
Assistance Publique - Hôpitaux de ParisCompletedRespiration | Ventilator Weaning | Hand StrengthFrance
-
Hannah SchaeferRecruitingKidney Disease | Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Radiation NephropathyGermany
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting